# NovoCure Limited (NVCR) FY2026 YTD Q2 P&L / Income Statement

- Company: NovoCure Limited (NVCR)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0001645113-26-000062
- Page: https://plicit.ai/financials/nvcr/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/nvcr-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Geography

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenues**: 357,639,000 US dollars
- **Cost of revenues**: 80,035,000 US dollars
- **Gross profit**: 277,604,000 US dollars
- **Total operating costs and expenses**: 355,586,000 US dollars
- **Operating income (loss)**: negative 77,982,000 US dollars
- **Other income (expense), net (calculated)**: negative 3,728,000 US dollars
- **Income (loss) before income tax**: negative 81,710,000 US dollars
- **Income tax**: 5,086,000 US dollars
- **Net income (loss)**: negative 86,796,000 US dollars
- **UNITED STATES**: 198,911,000 US dollars
- **GERMANY**: 47,845,000 US dollars
- **FRANCE**: 44,225,000 US dollars
- **JAPAN**: 22,023,000 US dollars
- **Other international markets**: 33,884,000 US dollars
- **CHINA**: 10,751,000 US dollars
- **Research, development and clinical studies**: 109,784,000 US dollars
- **Sales and marketing**: 120,041,000 US dollars
- **General and administrative**: 125,761,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details

- Page: https://plicit.ai/financials/nvcr/fy2026-ytd-q2-income-statement/views/view-5c917cba418b03bdb8f6
- Chart image: https://plicit.ai/charts/nvcr-fy2026-ytd-q2-income-statement-view-view-5c917cba418b03bdb8f6-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Revenue, Performance Obligation, Period Obligation Was Satisfied In. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenues**: 357,639,000 US dollars
- **Cost of revenues**: 80,035,000 US dollars
- **Gross profit**: 277,604,000 US dollars
- **Total operating costs and expenses**: 355,586,000 US dollars
- **Operating income (loss)**: negative 77,982,000 US dollars
- **Other income (expense), net (calculated)**: negative 3,728,000 US dollars
- **Income (loss) before income tax**: negative 81,710,000 US dollars
- **Income tax**: 5,086,000 US dollars
- **Net income (loss)**: negative 86,796,000 US dollars
- **Reporting period**: 343,986,000 US dollars
- **Previous periods**: 13,653,000 US dollars
- **Research, development and clinical studies**: 109,784,000 US dollars
- **Sales and marketing**: 120,041,000 US dollars
- **General and administrative**: 125,761,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.